News

First study to compare safety and efficacy of clopidogrel and aspirin monotherapy beyond 12 months in high-risk PCI population

MHIF is coordinating center for PROGRESS-CTO registry, which began in 2012 under the leadership of Dr. Emmanouil Brilakis, to advance care for CTO patients around the world

New financing will further support the development of FastWave’s proprietary intravascular lithotripsy systems.

We CARE 2022: Understanding the economic and societal burden of the pandemic

May 19, 2022, DANVERS, Mass.--Abiomed will feature the most recent Impella research and technological advances aimed at improving outcomes for acute myocardial infarction cardiogenic shock (AMICS) patients during the Society for...

New analysis of the largest Harmony TPV recipients cohort show echoes initial acute findings

Percutaneous Coronary Interventions Remain Below Pre-Pandemic Levels

Results Offer New Treatment Pathway for Underrepresented High-Risk Patient Population

Nationwide study points to implicit bias in treatment of cardiovascular disease for non-Hispanic black patients and highlights need for equity.

Guideline represents the most comprehensive effort to date to synthesize and interpret the evidence supporting PFO closure in a wide variety of clinical scenarios